NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $45,000 | -66.2% | 27,500 | 0.0% | 0.02% | -60.0% |
| Q3 2018 | $133,000 | -22.7% | 27,500 | 0.0% | 0.06% | -32.1% |
| Q2 2018 | $172,000 | -24.6% | 27,500 | 0.0% | 0.08% | -27.0% |
| Q1 2018 | $228,000 | -18.9% | 27,500 | 0.0% | 0.11% | -26.5% |
| Q4 2017 | $281,000 | +11.5% | 27,500 | 0.0% | 0.15% | -3.2% |
| Q3 2017 | $252,000 | -83.6% | 27,500 | -86.9% | 0.16% | -85.7% |
| Q2 2017 | $1,532,000 | +123.3% | 209,873 | +120.3% | 1.09% | +88.4% |
| Q1 2017 | $686,000 | +202.2% | 95,273 | +145.1% | 0.58% | +191.5% |
| Q4 2016 | $227,000 | -11.3% | 38,873 | 0.0% | 0.20% | +11.8% |
| Q3 2016 | $256,000 | -29.1% | 38,873 | 0.0% | 0.18% | -37.8% |
| Q2 2016 | $361,000 | -13.8% | 38,873 | 0.0% | 0.29% | -20.8% |
| Q1 2016 | $419,000 | -53.9% | 38,873 | -38.7% | 0.36% | -55.4% |
| Q4 2015 | $908,000 | -31.8% | 63,400 | 0.0% | 0.81% | -38.8% |
| Q3 2015 | $1,332,000 | – | 63,400 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,858,889 | $7,337,000 | 5.11% |
| Proxima Capital Management, LLC | 170,294 | $257,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,530,731 | $5,331,000 | 0.44% |
| Nantahala Capital Management | 4,610,000 | $6,961,000 | 0.21% |
| Wealthstar Advisors, LLC | 73,295 | $111,000 | 0.07% |
| Alambic Investment Management, L.P. | 51,733 | $78,000 | 0.06% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $151,000 | 0.05% |
| BCS Wealth Management | 29,520 | $45,000 | 0.03% |
| Allred Capital Management, LLC | 24,995 | $37,742,000 | 0.02% |
| ALGERT GLOBAL LLC | 34,254 | $52,000 | 0.02% |